External Use Authorized ...
Becoming a substantial holder
Filed with ASX ·
6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- CLINUVEL's injectable peptide platform
- Commercial update on vitiligo
- Update - SCENESSE in vitiligo
- CLINUVEL implements strategic reorganisation to refocus on U.S. markets
- CLINUVEL strategic reorganisation to refocus on U.S. markets
Later from Clinuvel Pharmaceuticals
- CLINUVEL Annual Results - Investor Webinar
- Dividend/Distribution - CUV
- Corporate Governance Statement
- Appendix 4G
- Investor Presentation
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals